Literature DB >> 20226853

Hypochlorite modification of sphingomyelin generates chlorinated lipid species that induce apoptosis and proteome alterations in dopaminergic PC12 neurons in vitro.

Christoph Nusshold1, Manfred Kollroser, Harald Köfeler, Gerald Rechberger, Helga Reicher, Andreas Ullen, Eva Bernhart, Sabine Waltl, Ingrid Kratzer, Albin Hermetter, Hubert Hackl, Zlatko Trajanoski, Andelko Hrzenjak, Ernst Malle, Wolfgang Sattler.   

Abstract

Recent observations link myeloperoxidase (MPO) activation to neurodegeneration. In multiple sclerosis MPO is present in areas of active demyelination where the potent oxidant hypochlorous acid (HOCl), formed by MPO from H(2)O(2) and chloride ions, could oxidatively damage myelin-associated lipids. The purpose of this study was (i) to characterize reaction products of sphingomyelin (SM) formed in response to modification by HOCl, (ii) to define the impact of exogenously added SM and HOCl-modified SM (HOCl-SM) on viability parameters of a neuronal cell line (PC12), and (iii) to study alterations in the PC12 cell proteome in response to SM and HOCl-SM. MALDI-TOF-MS analyses revealed that HOCl, added as reagent or generated enzymatically, transforms SM into chlorinated species. On the cellular level HOCl-SM but not SM induced the formation of reactive oxygen species. HOCl-SM induced severely impaired cell viability, dissipation of the mitochondrial membrane potential, and activation of caspase-3 and DNA damage. Proteome analyses identified differential expression of specific subsets of proteins in response to SM and HOCl-SM. Our results demonstrate that HOCl modification of SM results in the generation of chlorinated lipid species with potent neurotoxic properties. Given the emerging connections between the MPO-H(2)O(2)-chloride axis and neurodegeneration, this chlorinating pathway might be implicated in neuropathogenesis. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20226853      PMCID: PMC4061462          DOI: 10.1016/j.freeradbiomed.2010.02.037

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  57 in total

1.  Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis.

Authors:  R M Nagra; B Becher; W W Tourtellotte; J P Antel; D Gold; T Paladino; R A Smith; J R Nelson; W F Reynolds
Journal:  J Neuroimmunol       Date:  1997-09       Impact factor: 3.478

Review 2.  Mitochondrial fragmentation in neurodegeneration.

Authors:  Andrew B Knott; Guy Perkins; Robert Schwarzenbacher; Ella Bossy-Wetzel
Journal:  Nat Rev Neurosci       Date:  2008-07       Impact factor: 34.870

3.  Aberrant expression of myeloperoxidase in astrocytes promotes phospholipid oxidation and memory deficits in a mouse model of Alzheimer disease.

Authors:  Richard A Maki; Vladimir A Tyurin; Robert C Lyon; Ronald L Hamilton; Steven T DeKosky; Valerian E Kagan; Wanda F Reynolds
Journal:  J Biol Chem       Date:  2008-12-05       Impact factor: 5.157

4.  Maturation of the axonal plasma membrane requires upregulation of sphingomyelin synthesis and formation of protein-lipid complexes.

Authors:  M D Ledesma; B Brügger; C Bünning; F T Wieland; C G Dotti
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

5.  The vinyl ether linkages of plasmalogens are favored targets for myeloperoxidase-derived oxidants: a kinetic study.

Authors:  Ojia Skaff; David I Pattison; Michael J Davies
Journal:  Biochemistry       Date:  2008-07-08       Impact factor: 3.162

6.  Focal astrocyte loss is followed by microvascular damage, with subsequent repair of the blood-brain barrier in the apparent absence of direct astrocytic contact.

Authors:  Colin L Willis; Christopher C Nolan; Sharon N Reith; Timothy Lister; Malcolm J W Prior; Christopher J Guerin; George Mavroudis; David E Ray
Journal:  Glia       Date:  2004-03       Impact factor: 7.452

7.  Mass-spectrometric characterization of phospholipids and their primary peroxidation products in rat cortical neurons during staurosporine-induced apoptosis.

Authors:  Vladimir A Tyurin; Yulia Y Tyurina; Weihong Feng; Alexandra Mnuskin; Jianfei Jiang; Minke Tang; Xiaojing Zhang; Qing Zhao; Patrick M Kochanek; Robert S B Clark; Hülya Bayir; Valerian E Kagan
Journal:  J Neurochem       Date:  2008-11-06       Impact factor: 5.372

8.  Elevated myeloperoxidase activity in white matter in multiple sclerosis.

Authors:  Elizabeth Gray; Taya Louise Thomas; Samar Betmouni; Neil Scolding; Seth Love
Journal:  Neurosci Lett       Date:  2008-08-15       Impact factor: 3.046

9.  Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease.

Authors:  W F Reynolds; J Rhees; D Maciejewski; T Paladino; H Sieburg; R A Maki; E Masliah
Journal:  Exp Neurol       Date:  1999-01       Impact factor: 5.330

10.  A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis.

Authors:  David Wheeler; Veera Venkata Ratnam Bandaru; Peter A Calabresi; Avindra Nath; Norman J Haughey
Journal:  Brain       Date:  2008-09-04       Impact factor: 13.501

View more
  12 in total

1.  Formation of chlorinated lipids post-chlorine gas exposure.

Authors:  David A Ford; Jaideep Honavar; Carolyn J Albert; Mark A Duerr; Joo Yeun Oh; Stephen Doran; Sadis Matalon; Rakesh P Patel
Journal:  J Lipid Res       Date:  2016-06-20       Impact factor: 5.922

2.  Role of Peroxiredoxin 2 in the Protection Against Ferrous Sulfate-Induced Oxidative and Inflammatory Injury in PC12 Cells.

Authors:  Wenzhe Xu; Feng Li; Zhenkuan Xu; Bin Sun; Jingwei Cao; Yuguang Liu
Journal:  Cell Mol Neurobiol       Date:  2017-09-04       Impact factor: 5.046

3.  Identification of glutathione adducts of α-chlorofatty aldehydes produced in activated neutrophils.

Authors:  Mark A Duerr; Rajeev Aurora; David A Ford
Journal:  J Lipid Res       Date:  2015-03-26       Impact factor: 5.922

4.  Bromofatty aldehyde derived from bromine exposure and myeloperoxidase and eosinophil peroxidase modify GSH and protein.

Authors:  Mark A Duerr; Elisa N D Palladino; Celine L Hartman; James A Lambert; Jacob D Franke; Carolyn J Albert; Sadis Matalon; Rakesh P Patel; Arne Slungaard; David A Ford
Journal:  J Lipid Res       Date:  2018-02-14       Impact factor: 5.922

5.  Lipid oxidation by hypochlorous acid: chlorinated lipids in atherosclerosis and myocardial ischemia.

Authors:  David A Ford
Journal:  Clin Lipidol       Date:  2010-12-01

6.  Mouse brain plasmalogens are targets for hypochlorous acid-mediated modification in vitro and in vivo.

Authors:  Andreas Ullen; Günter Fauler; Harald Köfeler; Sabine Waltl; Christoph Nusshold; Eva Bernhart; Helga Reicher; Hans-Jörg Leis; Andrea Wintersperger; Ernst Malle; Wolfgang Sattler
Journal:  Free Radic Biol Med       Date:  2010-08-31       Impact factor: 7.376

7.  Linking Inflammation and Parkinson Disease: Hypochlorous Acid Generates Parkinsonian Poisons.

Authors:  Thomas M Jeitner; Mike Kalogiannis; Boris F Krasnikov; Irving Gomolin; Morgan R Peltier; Graham R Moran
Journal:  Toxicol Sci       Date:  2016-03-29       Impact factor: 4.849

8.  Assessment of electrophile damage in a human brain endothelial cell line utilizing a clickable alkyne analog of 2-chlorohexadecanal.

Authors:  Christoph Nusshold; Andreas Üllen; Nora Kogelnik; Eva Bernhart; Helga Reicher; Ioanna Plastira; Toma Glasnov; Klaus Zangger; Gerald Rechberger; Manfred Kollroser; Günter Fauler; Heimo Wolinski; Babette B Weksler; Ignacio A Romero; Sepp D Kohlwein; Pierre-Olivier Couraud; Ernst Malle; Wolfgang Sattler
Journal:  Free Radic Biol Med       Date:  2015-11-11       Impact factor: 7.376

9.  Phloretin ameliorates 2-chlorohexadecanal-mediated brain microvascular endothelial cell dysfunction in vitro.

Authors:  Andreas Ullen; Günter Fauler; Eva Bernhart; Christoph Nusshold; Helga Reicher; Hans-Jörg Leis; Ernst Malle; Wolfgang Sattler
Journal:  Free Radic Biol Med       Date:  2012-08-25       Impact factor: 7.376

10.  A versatile ultra-high performance LC-MS method for lipid profiling.

Authors:  Oskar L Knittelfelder; Bernd P Weberhofer; Thomas O Eichmann; Sepp D Kohlwein; Gerald N Rechberger
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-01-29       Impact factor: 3.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.